International Journal of Clinical Pharmacology & Pharmacotherapy Volume 1 (2016), Article ID 1:IJCPP-112, 8 pages
Review Article
The Medical use of Lemon Balm (Melissa officinalis) and Valerian (Valeriana officinalis) as Natural Sedatives: Insight into their Interactions with GABA Transmission

Stéphanie Pineau, Christian Legros and César Mattei*

Laboratory of Neurovascular and Mitochondrial Integrated Biology, UMR CNRS 6214, INSERM 1083, Faculty of Medicine, University of Angers, France
Dr. César Mattei, Laboratory of Neurovascular and Mitochondrial Integrated Biology, UMR CNRS 6214, INSERM U1083, Faculty of Medecine, University of Angers, Rue Haute de Reculée F-49045 Angers cedex 01 France, Tel: +33-2-41-73-58-79; E-mail:
31 March 2016; 30 June 2016; 02 July 2016
Pineau S, Legros C, Mattei C (2016) The Medical use of Lemon Balm (Melissa officinalis) and Valerian (Valeriana officinalis) as Natural Sedatives: Insight into their Interactions with GABA Transmission. Int J Clin Pharmacol Pharmacother 1: 112. doi:


  1. WHO (2011) in: World Health Organization (Ed.), The world medicines situation 2011: traditional medicines: Global situation, issues and challenges – 3rd edition – Geneva, Switzerland : Department for International Development
  2. Graziose R, Lila MA, Raskin I (2010) Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. Curr Drug Discov Technol 7: 2-12 [CrossRef] [Google Scholar] [PubMed]
  3. European Union (2001) Directive 2001/83/EC of the Eeuropean parliament and of the council of 6 November 2001 on the Community code relating to medicinal products for human use. OJ L 311, 28.11.2001, p. 67
  4. Ezuruike UF, Prieto JM2 (2014) The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations. J Ethnopharmacol 155: 857-924 [CrossRef] [Google Scholar] [PubMed]
  5. European Medicines Agency (2013) Community herbal monograph on Melissa officinalis L., folium. London, UK
  6. European Medicines Agency (2015) European Union herbal monograph on Valeriana officinalis L., radix, London, UK
  7. Ulbricht C, Brendler T, Gruenwald J, Kligler B, Keifer D, et al. (2005) Lemon balm (Melissa officinalis L.): an evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother 5: 71-114 [CrossRef] [Google Scholar] [PubMed]
  8. Bos R, Woerdenbag HJ, van Putten FM, Hendriks H, Scheffer JJ (1998a) Seasonal variation of the essential oil, valerenic acid and derivatives, and velopotriates in Valeriana officinalis roots and rhizomes, and the selection of plants suitable for phytomedicines. Planta Med 64: 143-147 [CrossRef] [Google Scholar] [PubMed]
  9. Sari AO, Ceylan A (2002) Yield characteristics and essential oil composition of lemon balm (Melissa officinalis L.) grown in the Aegean region of Turkey. Turk J Agric For 26: 217-224. [Google Scholar]
  10. Carnat AP, Carnat A, Fraisse D, Lamaison JL (1998) The aromatic and polyphenolic composition of lemon balm (Melissa officinalis L. subsp. officinalis) tea. Pharm Acta Helv 72: 301-305 [CrossRef] [Google Scholar]
  11. WHO (1999a) in: World Health Organization (Ed.), WHO monographs on selected medicinal plants. Vol. 2 - Geneva, Switzerland. 357 p
  12. WHO (1999b) in: World Health Organization (Ed.), WHO monographs on selected medicinal plants. Vol. 1 - Geneva, Switzerland. 295 p
  13. Gruenwald J, Brendler T, Jaenicke C (2007) Physician's Desk Reference (PDR) for herbal medicines-4th edition - Montval, New-Jersey, USA : Thompson, 1026 p
  14. Bent S, Padula A, Moore D, Patterson M, Mehling W (2006) Valerian for sleep: a systematic review and meta-analysis. Am J Med 119: 1005-1012 [CrossRef] [Google Scholar] [PubMed]
  15. Fernández-San-Martín MI1, Masa-Font R, Palacios-Soler L, Sancho- Gómez P, Calbó-Caldentey C, et al. (2010) Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med 11: 505-511 [CrossRef] [Google Scholar] [PubMed]
  16. Awad R, Levac D, Cybulska P, Merali Z, Trudeau VL, et al. (2007) Effects of traditionally used anxiolytic botanicals on enzymes of the gammaaminobutyric acid (GABA) system. Can J Physiol Pharmacol 85: 933-942 [CrossRef] [Google Scholar] [PubMed]
  17. Awad R, Muhammad A, Durst T, Trudeau VL, Arnason JT (2009) Bioassayguided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytother Res 23: 1075-1081 [CrossRef] [Google Scholar] [PubMed]
  18. López V, Martín S, Gómez-Serranillos MP, Carretero ME, Jäger AK, et al. (2009) Neuroprotective and neurological properties of Melissa officinalis. Neurochem Res 34: 1955-1961 [CrossRef] [Google Scholar] [PubMed]
  19. Rudolph U, Knoflach F (2011) Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 10: 685-697 [CrossRef] [Google Scholar] [PubMed]
  20. Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, et al. (2008) Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine 15: 2-15 [CrossRef] [Google Scholar] [PubMed]
  21. Murphy K, Kubin ZJ, Shepherd JN, Ettinger RH (2010) Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine 17: 674-678 [CrossRef] [Google Scholar] [PubMed]
  22. Rezvani ME, Roohbakhsh A, Allahtavakoli M, Shamsizadeh A (2010) Anticonvulsant effect of aqueous extract of Valeriana officinalis in amygdalakindled rats: possible involvement of adenosine. J Ethnopharmacol 127: 313-318 [CrossRef] [Google Scholar] [PubMed]
  23. Emami-Abarghouei M, Vafaei A, Akhavan MM, Taherian AA, Saberian E (2009) The effect of hydro-alcoholic extract of Valeriana officinalis on the ileum movement of guinea pig. J Gorgan Uni Med Sci 11: 1-5 [Google Scholar]
  24. Müller SF, Klement S (2006) A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine 13: 383-387 [CrossRef] [Google Scholar] [PubMed]
  25. Kennedy DO, Little W, Haskell CF, Scholey AB (2006) Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res 20: 96-102 [CrossRef] [PubMed]
  26. Cerny A, Schmid K (1999) Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double-blind, placebo-controlled, multicentre study). Fitoterapia 700: 221-228 [CrossRef] [Google Scholar]
  27. Pereira P, Tysca D, Oliveira P, da Silva Brum LF, Picada JN, et al. (2005) Neurobehavioral and genotoxic aspects of rosmarinic acid. Pharmacol Res 52: 199-203 [CrossRef] [Google Scholar] [PubMed]
  28. Geller F, Schmidt C, Göttert M, Fronza M, Schattel V, et al. (2010) Identification of rosmarinic acid as the major active constituent in Cordia americana. J Ethnopharmacol 128: 561-566 [CrossRef] [Google Scholar] [PubMed]
  29. Petersen M, Simmonds MS (2003) Rosmarinic acid. Phytochemistry 62: 121-125 [CrossRef] [Google Scholar] [PubMed]
  30. Liu J1 (1995) Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 49: 57-68 [CrossRef] [Google Scholar] [PubMed]
  31. Aoshima H, Hamamoto K (1999) Potentiation of GABAA receptors expressed in Xenopus oocytes by perfume and phytoncid. Biosci Biotechnol Biochem 63: 743-748 [CrossRef] [Google Scholar] [PubMed]
  32. Teuscher E, Anton R, Lobstein A (2005) Plantes aromatiques : épices, aromates, condiments et huiles essentielles-Paris, France : Ed. Tec & Doc
  33. Bos R, Woerdenbag HJ, Hendriks H, Scheffer JJC (1997) Composition of the essential oils from underground parts of Valeriana officinalis L. s.l. and several closely related taxa. Flavour and fragrance journal 12: 359-370 [CrossRef] [Google Scholar]
  34. Granger RE, Campbell EL, Johnston GA (2005) (+)- And (-)-borneol: efficacious positive modulators of GABA action at human recombinantalpha1beta2gamma2L GABA(A) receptors. Biochem Pharmacol 69: 1101-1111 [CrossRef] [Google Scholar] [PubMed]
  35. Cho JY, Hwang JK, Chun HS (2011) Xanthorrhizol attenuates dextran sulfate sodium-induced colitis via the modulation of the expression of inflammatory genes in mice. Life Sci 88: 864-870 [CrossRef] [Google Scholar] [PubMed]
  36. Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, et al. (2004) The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 98: 353-358, table of contents [CrossRef] [Google Scholar] [PubMed]
  37. Khom S, Strommer B, Ramharter J, Schwarz T, Schwarzer C, et al. (2010) Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands - in vitro and in vivo characterization. Br J Pharmacol 161: 65-78 [CrossRef] [Google Scholar] [PubMed]
  38. Khom S, Baburin I, Timin E, Hohaus A, Trauner G, et al. (2007) Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology 53: 178-187 [CrossRef] [Google Scholar] [PubMed]
  39. Benke D, Barberis A, Kopp S, Altmann KH, Schubiger M, et al. (2009) GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology 56: 174-181 [CrossRef] [Google Scholar] [PubMed]
  40. Whiting PJ (2003) GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today 8: 445-450 [CrossRef] [Google Scholar] [PubMed]
  41. Buchbauer G, Jirovetz L, Jäger W, Plank C, Dietrich H (1993) Fragrance compounds and essential oils with sedative effects upon inhalation. J Pharm Sci 82: 660-664 [CrossRef] [Google Scholar] [PubMed]
  42. Hossain SJ, Hamamoto K, Aoshima H, Hara Y (2002) Effects of tea components on the response of GABA(A) receptors expressed in Xenopus Oocytes. J Agric Food Chem 50: 3954-3960 [CrossRef] [Google Scholar] [PubMed]
  43. Lacher SK, Mayer R, Sichardt K, Nieber K Et Müller CE (2007) Interaction of valerian extracts of different polarity with adenosine receptors : identification of isovaltrate as an inverse agonist at A1 receptors. Biochem Pharmacol 73: 248-258 [CrossRef] [Google Scholar] [PubMed]
  44. Nichols DE, Nichols CD (2008) Serotonin receptors. Chem Rev 108: 1614- 1641 [CrossRef] [Google Scholar] [PubMed]
  45. Dietz BM, Mahady GB, Pauli GF, Farnsworth NR (2005) Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res 138: 191-197 [CrossRef] [Google Scholar] [PubMed]
  46. Bos R, Hendriks H, Scheffer JJ, Woerdenbag HJ (1998) Cytotoxic potential of valerian constituents and valerian tinctures. Phytomedicine 5: 219-225 [CrossRef] [Google Scholar] [PubMed]
  47. Santini F, Vitti P, Ceccarini G, Mammoli C, Rosellini V, et al. (2003) In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest 26: 950-955 [CrossRef] [Google Scholar] [PubMed]
  48. Sköld M, Karlberg AT, Matura M, Börje A (2006) The fragrance chemical beta-caryophyllene-air oxidation and skin sensitization. Food Chem Toxicol 44: 538-545 [CrossRef] [Google Scholar] [PubMed]
  49. Mesa-Arango AC, Montiel-Ramos J, Zapata B, Durán C, Betancur-Galvis L, et al. (2009) Citral and carvone chemotypes from the essential oils of Colombian Lippia alba (Mill.) N.E. Brown: composition, cytotoxicity and antifungal activity. Mem Inst Oswaldo Cruz 104: 878-884 [CrossRef] [Google Scholar] [PubMed]
  50. Miller PS, Aricescu AR (2014) Crystal structure of a human GABAA receptor. Nature 512: 270-275 [CrossRef] [Google Scholar] [PubMed]
  51. Sieghart W (2015) Allosteric modulation of GABAA receptors via multiple drug-binding sites. Adv Pharmacol 72: 53-96 [CrossRef] [Google Scholar] [PubMed]
  52. Farrant M, Nusser Z (2005) Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 6: 215-229 [CrossRef] [Google Scholar] [PubMed]